AHSAX
Price
$18.16
Change
-$0.26 (-1.41%)
Updated
May 8 closing price
Net Assets
68.09M
FSPHX
Price
$25.23
Change
-$0.05 (-0.20%)
Updated
May 8 closing price
Net Assets
6.2B
Ad is loading...

AHSAX vs FSPHX

Header iconAHSAX vs FSPHX Comparison
Open Charts AHSAX vs FSPHXBanner chart's image
Alger Health Sciences A
Price$18.16
Change-$0.26 (-1.41%)
VolumeN/A
Net Assets68.09M
Fidelity Select Health Care
Price$25.23
Change-$0.05 (-0.20%)
VolumeN/A
Net Assets6.2B
AHSAX vs FSPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AHSAX vs. FSPHX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AHSAX is a Buy and FSPHX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.2B vs. AHSAX (68.1M). FSPHX pays higher dividends than AHSAX: FSPHX (0.02) vs AHSAX (0.00). AHSAX was incepted earlier than FSPHX: AHSAX (23 years) vs FSPHX (44 years). AHSAX (1.18) is less costly to investors than FSPHX (0.63). AHSAX is a more actively managed with annual turnover of: 233.38 vs. FSPHX (40.00). FSPHX has a lower initial minimum investment than AHSAX: FSPHX (0) vs AHSAX (1000). FSPHX annual gain was more profitable for investors over the last year : -11.31 vs. AHSAX (-15.04). FSPHX return over 5 years is better than : -11.47 vs. AHSAX (-34.84).
AHSAXFSPHXAHSAX / FSPHX
Total Expense Ratio1.180.63187%
Annual Report Gross Expense Ratio1.180.63187%
Fund Existence23 years44 years-
Gain YTD-11.014-7.229152%
Front Load5%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets68.1M6.2B1%
Annual Yield % from dividends0.000.02-
Returns for 1 year-15.04-11.31133%
Returns for 3 years-3.215.18-62%
Returns for 5 years-34.84-11.47304%
Returns for 10 years-23.388.19-285%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMPEX24.910.38
+1.55%
Beck Mack + Oliver Partners
WBENX12.40N/A
N/A
William Blair Emerging Mkts Growth N
IJSIX14.82N/A
N/A
VY® JPMorgan Small Cap Core Equity I
VMACX56.24N/A
N/A
Virtus KAR Mid-Cap Core A
AULYX91.91N/A
N/A
American Century Ultra® Y